PROVIDER EDUCATION

A SPECIAL TRAINING OPPORTUNITY AT UCSD!

You are invited to participate in a live continuing education program designed to provide practical training and clinical insights into the use of intralesional oncolytic therapies for melanoma. This initiative, held at the University of California, San Diego, is supported by the UC Melanoma and Skin Cancer Consortium (UCMSCC) and features additional UC expert faculty.

Current educational offerings:

New CE/CME/CPE Activity with Opportunity for Hands-on Training: Oncolytic Therapy for Melanoma: An APP-focused Educational Curriculum

***No longer available for credit***

Oncolytic therapy, introduced a decade ago, is gaining momentum as a promising treatment for melanoma. Advanced practice providers play a key role in implementing therapies like intralesional injections and require education, skill development, and credentialing support as they adopt oncolytic virotherapy. This APSHO-endorsed curriculum offers didactic content, instructional videos, and future hands-on training opportunities to support the expanded use of oncolytic therapies in clinical practice.